Aimei Health Technology (AFJK) Fundamentals 2026 — P/E 69.6x, Revenue Analysis | SniperIQ

1.66 on the NASDAQ. This SniperIQ fundamentals page covers Aimei Health Technology's valuation (P/E 69.6x, P/B 1.5x), profitability (net margin 0.0%), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Aimei Health Technology's market cap?

Aimei Health Technology (AFJK) has a market capitalization of approximately $71M, trading at

1.66 on the NASDAQ. Market cap moves with the live share price.

What is Aimei Health Technology's P/E ratio?

Aimei Health Technology's trailing twelve-month P/E ratio is 69.6x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.

How profitable is Aimei Health Technology?

Aimei Health Technology runs a net profit margin of 0.0%, a gross margin of 0.0%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

Does Aimei Health Technology pay a dividend?

Aimei Health Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Aimei Health Technology financially healthy?

Aimei Health Technology carries a debt-to-equity ratio of 0.26x and a current ratio of 0.01x, with a market beta of 0.55. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Aimei Health Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Aimei Health Technology (AFJK) the key facts are: market cap $71M, P/E 69.6x, 52-week range 6.75-130.37. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.